Hemodynamic responses to angiotensin-(1-7) in women in their third trimester of pregnancy

References

• Merrill DC, Karoly M, Chen K, et al. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002;18:239–45
   PubMed Web of Science ®Google Scholar
• Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682–9
   PubMed Web of Science ®Google Scholar
• Benjamin N, Rymer J, Todd SD, et al. Sensitivity to angiotensin II of forearm resistance vessels in pregnancy. Br J Clin Pharmacol 1991;32:523–5
   PubMed Web of Science ®Google Scholar
• Gant NF, Whalley PJ, Everett RB, et al. Control of vascular reactivity in pregnancy. Am J Kid Dis 1987;IX:303–7
   Google Scholar
• Santos RAS, Brosnihan KB, Jacobsen DW, et al. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension (Suppl II) 1992;19:II-56–61
   Web of Science ®Google Scholar
• Valdes G, Neves LA, Anton L, et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta 2006;27:200–7
   PubMed Web of Science ®Google Scholar
• Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. ajp heart and circulatory 2005;289:H1560–6
   PubMed Web of Science ®Google Scholar
• Santos RA, Ferreira AJ, Simoes e Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008;93:519–27
   PubMed Web of Science ®Google Scholar
• Neves LAA, Williams AF, Averill DB, et al. Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology 2003;14:3338–43
   Google Scholar
• Sampaio WO, Nascimento AAS, Santos RA. Regulation of cardiovascular signaling by Kinins and products of similar converting enzyme systems. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am J Physiol Heart Circ Physiol 2003;284:H1985–94
   PubMed Web of Science ®Google Scholar
• Belardinelli L, Shryock J, West A, et al. Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts. Circulation 1984;70:1083–91
   PubMed Web of Science ®Google Scholar
• Burchell SA, Yu M, Takiguchi SA, et al. Evaluation of a continuous cardiac output and mixed venous oxygen saturation catheter in critically ill surgical patients. Crit Care Med 1997;25:388–91
   PubMed Web of Science ®Google Scholar
• Sasaki S, Higashi Y, Nakagawa K, et al. Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension. Hypertension 2001;38:90–4
   PubMed Web of Science ®Google Scholar
• Ueda S, Masumori-Maemoto S, Wada A, et al. Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. J Hypertens 2001;19:2001–9
   PubMed Web of Science ®Google Scholar
• Petrie JR, Ueda S, Morris AD, et al. How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol 1998;45:131–9
   PubMed Web of Science ®Google Scholar
• Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 2008;18:109–16
   PubMed Web of Science ®Google Scholar
• Ekenvall L, Lindblad LE, Norbeck O, Etzell BM. Alpha-adrenoceptors and cold-induced vasoconstriction in human finger skin. Am J Physiol 1988;255:H1000–3
   PubMedGoogle Scholar
• Eneroth-Grimfors E, Lindblad LE, Westgren M, et al. Iontophoresis of vasoactive drugs. Effect on peripheral blood flow during pregnancy. Acta Obstet Gynecol Scand 1991;70:25–8
   PubMed Web of Science ®Google Scholar
• Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides 1993;14:883–91
   PubMed Web of Science ®Google Scholar
• Sampaio WO, Souza dos Santos RA, Faria-Silva R, et al. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007;49:185–92
   PubMed Web of Science ®Google Scholar
• Schindler C, Bramlage P, Kirch W, Ferrario CM. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag 2007;3:125–37
   PubMedGoogle Scholar
• Ferrario CM. Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology. Current Hypertens Reports 2003;5:129–34
   PubMed Web of Science ®Google Scholar
• Gironacci MM, Adamo HP, Corradi G, et al. Angiotensin (1-7) induces MAS receptor internalization. Hypertension 2011;58:176–81
   PubMedGoogle Scholar
• de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415–72
   PubMed Web of Science ®Google Scholar
• Wilsdorf T, Gainer JV, Murphey LJ, et al. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm. Hypertension 2001;37:1136–40
   PubMed Web of Science ®Google Scholar
• Ueda S, Masumpori-Maemoto S, Ashino K, et al. Angiotensin-(1-7) attenuates vasoconstriction evoked by Angiotensin II but not by noradrenaline in man. Hypertension 2000;35:998–1001
   PubMed Web of Science ®Google Scholar
• Weissgerber TL, Davies GAL, Tschakovsky ME. Brachial artery flow-mediated dilation is not affected by pregnancy or regular exercise participation. Clin Sci 2011;121:355–65
   Web of Science ®Google Scholar
• Savvidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. The Lancet 2003;361:1511–17
   PubMed Web of Science ®Google Scholar
• Campia U, Choucair WK, Bryant MB, et al. Reduced endothelium-dependent and -independent dilation of conductance arteries in African Americans. J Am Coll Cardiol 2002;40:754–60
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013;209:544.e1–12
   Web of Science ®Google Scholar
• Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol 1998;92:174–8
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200–4
   PubMed Web of Science ®Google Scholar
• Suboc TM, Dharmashankar K, Wang J, et al. Moderate obesity and endothelial dysfunction in humans: influence of gender and systemic inflammation. Physiol Rep 2013;1:1–10
   Google Scholar
• Tur E, Tamir A, Guy RH. Cutaneous blood flow in gestational hypertension and normal pregnancy. J Invest Dermatol 1992;99:310–14
   PubMed Web of Science ®Google Scholar
• Khan F, Belch JJ, MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension 2005;46:1123–8
   PubMed Web of Science ®Google Scholar
• Cankar K, Potocnik N, Strucl M. Alteration of skin laser-Doppler flux response to local cooling in gestational hypertension. Clin Auton Res 2010;20:183–90
   PubMed Web of Science ®Google Scholar
• Yoshida A, Nakao S, Kobayashi M, Kobayashi H. Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 2000;36:400–4
   PubMed Web of Science ®Google Scholar
• Takase B, Goto T, Hamabe A, et al. Flow-mediated dilation in brachial artery in the second half of pregnancy and prediction of pre-eclampsia. J Hum Hypertens 2003;17:697–704
   PubMed Web of Science ®Google Scholar